News & Updates
Filter by Specialty:
Perfluorohexyloctane eye drops for dry eye disease impresses in phase III trial
The novel NOV03 ophthalmic drop consisting of perfluorohexyloctane appears to help reduce both signs and symptoms of dry eye disease (DED) associated with meibomian gland dysfunction (MGD), as shown in the results of the phase III MOJAVE study.
Perfluorohexyloctane eye drops for dry eye disease impresses in phase III trial
25 Mar 2023
Less salt may be fatally counterproductive for people with heart failure
Too little salt is not necessarily better for individuals with heart failure, with the results of a recent meta-analysis suggesting that sodium restriction in this population increases the risk of death.
Less salt may be fatally counterproductive for people with heart failure
24 Mar 2023
Long-term dupilumab proven safe, effective in children with asthma
Long-term treatment with dupilumab is well tolerated, and its efficacy in children with uncontrolled, moderate-to-severe asthma as seen in the VOYAGE study is consistent, according to the EXCURSION open-label extension study. In addition, patients who switched from placebo to dupilumab has improved rapid lung function.